Medical Devices · IVD · SaMD

Complete Market Entry for Medical Devices

From device classification & regulatory approval to distributor onboarding, KOL activation & commercial sales — across 26 global markets.

ISO 13485
GMP Certified
GDPR Compliant
The Challenge

Most Firms Stop at Approval

Getting a registration certificate is step one. Without distribution, clinical validation, and sales infrastructure — your device sits on a shelf.

01·Classification Systems

The Regulatory Maze

Device classification varies by market. Class II in India may be Class III under MDR in Europe. Wrong classification means rejection, delay, and wasted cost.

Time to Market Comparison
Without Taevas18–24 months
With Taevas4–8 months
42%
Rejection Risk
3.2×
Cost Overrun
4–6
Markets Delayed
How Taevas Solves This

We handle classification in all 26 markets — mapping the correct pathway per authority before a single document is submitted.

0×
Faster with Taevas
vs. going alone
0
Markets Ready
In-country teams
0+
Brands Launched
Class I–III, IVD, SaMD
Our Services

Nine Services. One Team. Complete Access.

Available individually or as a full end-to-end market entry programme.

Market Intelligence

Regulatory landscape, competitive mapping, pricing intelligence, hospital procurement analysis.

Product Registration

Class A–D registration with CDSCO, TGA, MHRA, SFDA, CE — full dossier preparation.

Legal Representation

In-country Authorised Representative and Statutory Agent for MDR, IVDR, CDSCO, TGA.

Imports & Shipments

Import licence management, customs clearance, demo unit handling, port-to-hospital logistics.

Warehousing & Inventory

In-market storage, real-time inventory, cold-chain handling, capital equipment delivery.

Distributor Identification

Pre-qualified distributors by device category from our network across 26 markets.

End to End Marketing

Brand localisation, KOL engagement, clinical event support, digital marketing.

Sales Support

Hospital sales deployment, demo coordination, tender strategy, procurement engagement.

Our Process

Six Phases to Market Success

Click any phase to explore. Regulatory and commercial workstreams run in parallel.

Phase 01 of 06

Market Intelligence

Category SizingRegulatory MappingGo/No-Go

What We Do

Device category sizing, regulatory pathway mapping, competitive analysis, pricing intelligence, distributor landscape assessment, and go/no-go recommendation.

Taevas Advantage

Before committing a single document, we map the full landscape — so every decision that follows is data-driven.

1 / 6
Who This Is For

Built for These Device Manufacturers

International Device Manufacturer
New to Market

International Device Manufacturer

Foreign brand with CE Mark or FDA 510(k), entering India, Southeast Asia, or the Middle East for the first time.

We provide the complete market entry infrastructure — regulatory, distribution, clinical, and commercial — from day one.

Registered But Not Growing
Already Present

Registered But Not Growing

Registered in 1–2 markets but sales are flat. Distributor underperforming. No KOL programme, no tender presence.

We audit, rebuild the distributor, activate KOLs, and launch a structured sales programme.

Going to Market Direct
OEM Manufacturer

Going to Market Direct

Manufacturing under OEM contracts, now bringing own-label products directly to market across multiple geographies.

We manage the full journey under a single contract — your external market access team.

Why Taevas

Why Device Manufacturers Choose Taevas

0+
Device Brands
Class I–III, IVD, SaMD
0
Office Markets
In-country specialists
0
Services
Registration to sales
0
Regions
Active authorities

Specialist Device Team

Dedicated regulatory, clinical, and commercial specialists. Not generalists.

Pre-Qualified Distributors

Networks mapped, vetted, and qualified by device category across 26 markets.

Active KOL Relationships

Surgeons, cardiologists, radiologists, and clinicians in key markets.

Regulatory + Commercial

Same team handles registration and commercial launch. No handoff.

258+ Brands Launched

Class I–III, IVD, and SaMD platforms across every major market.

Post-Market Support

PMCF, vigilance, renewals, re-registration, and market withdrawal.

Case Highlights

What Success Looks Like

German Orthopaedic Implant Manufacturer
Germany → India

German Orthopaedic Implant Manufacturer

Class C orthopaedic implant system with CE Mark

CDSCO registration in 8 months. Distributor onboarded Month 9. First hospital tender Month 11. First commercial order Month 12.

South Korean Imaging Company
South Korea → SE Asia

South Korean Imaging Company

Capital imaging equipment

Parallel registrations across 14 months. 6 distributors activated. Regional sales deployed by Month 15.

US SaMD Platform
USA → India, UAE

US SaMD Platform

AI-powered diagnostic imaging analysis (SaMD)

CDSCO SaMD classification completed. 12-hospital partnership in India. Pilot revenue Month 11.

Case Study: VNG System Rollout across 12 ENT Clinics | Taevas Global